• Hypoxia-Immunometabolism in the Tumor Microenvironment

  2026-08-23

  This 2025 Cancer Letters review integrates tumor hypoxia with immunometabolic competition to explain how oxygen and nutrient scarcity promote immune dysfunction, tumor adaptation, and progression. Its main practical contribution is a framework for studying tumor cells and immune cells as metabolically coupled populations rather than as isolated systems.

• Perospirone: From Receptors to Kv1.5 Assays

  2026-08-22

  Perospirone (SM-9018 free base) combines high-affinity serotonergic and dopaminergic receptor activity with a newly characterized vascular Kv-channel effect. This practical guide shows how to separate receptor pharmacology from ion-channel off-target testing in schizophrenia research and translational assays.

• G-1: Practical GPR30 Assay Guidance

  2026-08-22

  This scenario-based guide explains how G-1 (CAS 881639-98-1), a selective GPR30 agonist, can improve interpretation of viability, proliferation, migration, and cytotoxicity experiments. It connects SKU B5455 specifications with receptor biology, solvent handling, literature benchmarks, and practical vendor-selection criteria.

• Thapsigargin: SERCA Workflows for ER Stress

  2026-08-21

  Thapsigargin provides a rapid calcium-first perturbation for linking SERCA inhibition to endoplasmic reticulum stress, inflammasome signaling, and apoptosis. This practical guide covers assay design, comparative controls, protocol starting points, and troubleshooting for cell-based and disease-model workflows.

• Digestive Metabolism of Withania somnifera Extracts

  2026-08-20

  This 2026 study combines simulated gastrointestinal digestion, LC–MS/MS, targeted analysis, and untargeted molecular networking to examine how Withania somnifera leaf and root extracts change before absorption. Withaferin A and withanoside IV were labile, whereas withanolide A remained comparatively stable, demonstrating why botanical bioavailability requires matrix-aware digestive profiling.

• Cabozantinib: Mapping Adaptive Signaling in RCC

  2026-08-20

  Cabozantinib, also known as XL184, is more than a broad-spectrum kinase inhibitor: it is a practical model for studying how tumors rewire signaling over time. This thought-leadership analysis connects its VEGFR, MET, RET, AXL, and related RTK activity with phosphoproteomic evidence from renal cell carcinoma, translating those findings into experimental design, assay strategy, and a forward-looking framework for translational research.

• L-Phenylephrine and the Sex-Specific α1A Axis

  2026-08-19

  L-Phenylephrine offers translational researchers a selective adrenergic α1A receptor agonist for probing vascular, cardiac, neural, and sex-dependent physiology. By connecting receptor pharmacology with the sex-specific autonomic findings of angiotensin II hypertension research, this article presents a practical framework for assay design, validation, and translational interpretation.

• Quercetin Blocks Ferroptosis in Wilson’s Disease

  2026-08-19

  A 2026 Phytomedicine study identifies ferroptosis as a mechanistic contributor to Wilson’s disease-associated liver injury and shows that Quercetin protects experimental liver tissue by targeting the ACSL4/LPCAT3/ALOX15 lipid-peroxidation axis. The work combines animal and cell models with lipidomics, biophysical binding assays, and ACSL4 overexpression to connect altered phospholipid metabolism with hepatic protection.

• Dextrose (D-Glucose) in Metabolism Research

  2026-08-18

  Dextrose, or D-glucose, is a defined monosaccharide substrate for glucose metabolism research, cell culture media supplementation, and cellular energy production studies. Product specifications for A8406 support controlled preparation, while tumor-immunometabolism literature shows why glucose availability must be treated as an experimental variable rather than a neutral background condition.

• Estradiol Workflow for Estrogen Receptor Studies

  2026-08-18

  Build reproducible 17 beta-estradiol experiments that connect receptor activation with transcription, autophagy, and multi-organ phenotypes. This workflow emphasizes dose control, receptor-aware controls, and translational readouts for cardiovascular, renal, cancer, and endocrine research.

• Bestatin Hydrochloride: From Enzymes to Translation

  2026-08-17

  Bestatin hydrochloride, also known as Ubenimex, is more than a generic aminopeptidase inhibitor. Its ability to perturb aminopeptidase N and B activity creates a practical bridge between neuronal peptide processing, angiogenesis inhibition, and translational cancer research. This article examines the evidence, experimental design implications, and strategic opportunities for using the compound responsibly.

• Melittin Workflows for Glioblastoma Signaling

  2026-08-17

  Use Melittin as a dual-action GPCR signaling probe while separating pathway modulation from nonspecific loss of cell viability. This workflow connects Gs/Gi analysis with glioblastoma migration, apoptosis, and ferroptosis-oriented assay design without treating the peptide as a direct substitute for genetic or lipid-pathway manipulation.

• Ionomycin free acid in Reliable Cell Assays

  2026-08-16

  Learn how Ionomycin free acid (SKU B6947) can support controlled calcium ion transport, assay optimization, and interpretation of viability or proliferation data. This scenario-based guide connects product handling with practical controls and carefully distinguishes established product information from exploratory TNBC applications.

• Cannabidiol, FAAH, and Orofacial Pain Affective Deficits

  2026-08-15

  This mouse study shows that cannabidiol reduces both inflammatory orofacial nociception and pain-associated affective and cognitive deficits through coordinated peripheral and central mechanisms. Its findings connect FAAH-related endocannabinoid signaling, CB1 and CB2 receptor pathways, inflammatory mediators, and serotonergic activity, while also clarifying important limits for translation.

• Capecitabine in Gastric Cancer Assembloid Research

  2026-08-14

  Capecitabine offers a practical way to test tumor-selective fluoropyrimidine activation in patient-derived organoid and stromal co-culture systems. This workflow pairs viability measurements with thymidine phosphorylase, Fas, and tumor–stroma readouts to expose resistance mechanisms that monocultures can miss.

7951 records 1/531 page Next 12345 下5页 Last page